Track-and-trace provision missing from pharma law

Risk Management

Thursday, June 28, 2012

Congress passed the Food and Drug Administration Safety and Innovation Act this week, but did not include a provision aimed at improving supply chain safety. Among other things, the legislation will "for the first time, enable the FDA to: regularly inspect foreign drug manufacturing facilities, which supply 80 percent of the ingredients in our medications," said Allan Coukell, director of medical programs at the Pew Health Group. But UPS spokesman Kara Gerhardt Ross sa...

You have requested access to content only available to Registered Users of American Shipper. You can become a registered user for FREE. You will not have access to premium content.

Your registration to American Shipper is FREE and will provide you access to much of the content on the American Shipper Web site. You will not have access to Premium Content.

SUBSCRIBE NOW
Access to premium content, original reporting, research, and feature stories require a paid subscription. Subscriptions to American Shipper costs $120 a year. Your subscription includes unlimited access to content on the American Shipper Website, early access to the digital edition of the monthly magazine, and the daily AS+ premium newsletter published each morning.